Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a exciting advance in obesity treatment . Early research findings have demonstrated https://mountainbikegiantbicycle258974.empirewiki.com/10138316/emerging_medication_in_australia_a_potential_breakthrough_for_obesity_management